| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fedddce188dbb755496e1e1b5c76851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d65c5f197cab1660172962c7a0c8b9d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-918
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2009-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58580d1127b41a0679b32359865acf63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d078985e63451cba2481c636246ac1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1a4ffc25f4276f398266b49a7a3c81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e828b1287a991f5461bf6e9c6c6eb515 |
| publicationDate |
2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2556759-T3 |
| titleOfInvention |
Combination of sPLA2 activity and cardiovascular risk factors OxPL / apoB for diagnosis / prognosis of a disease / cardiovascular event |
| abstract |
A method to identify a subject that has or is at risk of having or developing a cardiovascular disease and / or a cardiovascular event, comprising: - measuring, in a sample obtained from said subject, at least two cardiovascular risk factors: a ) secreted phospholipase A2 activity (sPLA2) and b) apolipoprotein B-100 particles oxidized phospholipids (OxPL / apoB), - combining said measurements, the combined value of sPLA2 and OxPL / apoB activity is an indication that it has or is in risk of having or developing a cardiovascular disease and / or cardiovascular event. |
| priorityDate |
2008-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |